HOUSE 2038116th CongressReferred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
- Last Action
- 5/15/2019
Actions
- 2019-05-15Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
- 2019-04-02Referred to the House Committee on the Judiciary.
- 2019-04-02Introduced in House
- 2019-04-02Introduced in House
CRS Summary
As of 2019-04-02 (00)
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.
Cosponsors (2)
- Ted Budd (R-NC)
- Debbie Lesko (R-AZ)
Subjects
- Cancer
- Child health
- Child safety and welfare
- Congressional oversight
- Drug, alcohol, tobacco use
- Health care costs and insurance
- Health care coverage and access
- Health facilities and institutions
- Health personnel
- Health programs administration and funding
- Long-term, rehabilitative, and terminal care
- Prescription drugs
- Rural conditions and development
- Sales and excise taxes
- State and local finance
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.